LivaNova (Nasdaq:LIVN) this week posted fourth-quarter results that beat the overall consensus on Wall Street. The London-based company reported profits of $1.7 million, or 3¢ per share, on sales of $274.9 million for the three months ended Dec. 31, 2022, for a sales gain of 1.78% compared with Q4 2021. It also had a profit […]
Patient Monitoring
BioSig Technologies regains Nasdaq compliance
BioSig Technologies (Nasdaq:BSGM) announced today that it received notice from the Nasdaq market that it regained compliance. Westport, Connecticut-based BioSig regained compliance with the minimum bid price requirement. Shares of BSGM closed at or above $1 apeice for a period of 10 consecutive days earlier this month. The compliance period took place between Feb. 6 […]
DiabetesWise launches Prescription Tool to help providers pick devices for patients
DiabetesWise announced today that it launched its advanced Prescription Tool for the DiabetesWise Pro website. In April 2022, the company launched its DiabetesWise Pro website to help providers make informed decisions on diabetes devices. The easy-to-use and free tool offers access in the clinical practice or at the point of care. Providers can identify the […]
President Biden upholds ITC ruling favoring AliveCor in patent spat with Apple
AliveCor announced today that the final determination rule on its patent dispute with Apple cleared presidential review. In December, the International Trade Commission (ITC) ruled that the Apple Watch infringed AliveCor’s patented technology. Along with its final determination, the ITC issued a limited exclusion disorder (LEO) and a cease and desist order. It set a […]
Ascensia partners with Snaq on diabetes management
Ascensia Diabetes Care announced today that it entered into a global collaboration with diabetes management company Snaq. Snaq develops an app-based solution offering insights on food and nutrition for people with diabetes. Ascensia develops the Controu blood glucose monitoring system and distributes Senseonics’ Eversense CGM systems. The companies plan to integrate technologies to help with […]
Medicare to cover Dexcom G7 when it launches this week
Dexcom (Nasdaq:DXCM) announced today that Medicare offers coverage for its beneficiaries using the next-generation G7 CGM. The company announced the coming U.S. launch for G7 in a Super Bowl Commercial with musician Nick Jonas last night. It’s slated to roll out on Friday, Feb. 17. San Diego-based Dexcom met the category requirements for therapeutic continuous […]
Insulet acquires insulin pump patents from Bigfoot Biomedical for $25M
Insulet (Nasdaq:PODD) announced today that it acquired assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technologies. Acton, Massachusetts-based Insulet paid $25 million to acquire the AID assets. These include certain Bigfoot patents related to pumps that may be used for AID therapy. Insulet already develops its own AID technology with its Omnipod platform. The […]
Abbott is bullish on FreeStyle Libre growth in 2023
Abbott (NYSE:ABT) plans to “go more aggressively” into the continuous glucose monitor (CGM) market with its FreeStyle Libre 3 this year. Chair and CEO Robert Ford said on the company’s most recent earnings call that the company expects growth for the platform this year. FreeStyle Libre 3 received FDA clearance in May 2022. Ford cited full-year growth […]
Dexcom stock rises after hours on Street-beating Q4
Dexcom (Nasdaq:DXCM) shares ticked up after the market closed today on fourth-quarter results that topped the consensus forecast. Shares of DXCM rose 2.2% at $109.61 apiece after hours. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up 10.1%. The San Diego-based continuous glucose monitor […]
New medtech to watch for in 2023: boosting health outcomes
As earnings season is upon us, we’re receiving a clearer view of what new medtech could be launching this year in the medical device space. Companies still feel hamstrung by macroeconomic pressures, supply chain issues and more. However, many pointed out that 2023 has plenty to look forward to. Several quarterly reports and earnings calls […]
DarioHealth, Dexcom partner to integrate CGM into digital health platform
DarioHealth (Nasdaq:DRIO) announced today that it agreed with Dexcom (Nasdaq:DXCM) to integrate continuous glucose monitoring into its digital health platform. Dexcom CGM uses small, wearable sensors to continuously measure and send glucose levels to a receiver or smart device. The company’s latest CGM technology, the Dexcom G7, recently received FDA clearance. The company plans to […]